D-0603-2022 Class II Terminated
FDA drug recall D-0603-2022 was initiated by Perrigo Company PLC on Oct 26, 2021 and is designated Class II. Reason for recall: CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier. The recall status is terminated (terminated Sep 29, 2023). Affected quantity: 37,104 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 2, 2022
- Initiation Date
- Oct 26, 2021
- Termination Date
- Sep 29, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 37,104 bottles
Product description
Maximum Strength Plus Menthol No Drip Nasal Spray, Oxymetazoline HCl 0.05% Nasal Decongestant, 1 FL Oz (30 mL) per bottle, DISTRIBUTED BY: AMAZON.COM SERVICES LLC 410 TERRY AVENUE N.SEATTLE, WA 98109. NDC: 72288-703-10
Reason for recall
CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
Distribution pattern
Nationwide in the USA
Code information
Batch: 1FK1251, Exp 02/28/2023; 1BK0716, Exp 12/31/2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0603-2022
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026